Who
D. Keith Grossman
Director
Company insider
Files Form 4 as: Director, MiniMed Group; Director, Outset Medical; Executive Chairman, Nevro; Director, ViewRay; Director, Zeltiq Aesthetics; President & Chief Exec Officer, Thoratec; President & CEO, Conceptus; Director, Intuitive Surgical.
In numbers
- Trades disclosed
- 455
- Buys
- 2
- Sells
- 32
- Bought
- $939K
- Sold
- $20.6M
- Companies
- 9
- Companies where not an officer
- 6
- First trade
- 31 Jan 2006
- Last trade
- 9 Oct 2026
- Last filed
- 13 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Oct 2026filed 13 Oct 2026 | MMED MiniMed GroupMedical Devices | SEC FORM 4 Code A | —11,795 at $0.00 | filing |
| 4 Jun 2026filed 5 Jun 2026 | OM Outset MedicalMedical Devices | SEC FORM 4 Code A | —10,667 at $0.00 | filing |
| 4 Jun 2026filed 5 Jun 2026 | OM Outset MedicalMedical Devices | SEC FORM 4 Code A | —10,667 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | MMED MiniMed GroupMedical Devices | SEC FORM 4 Code A | —13,889 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | MMED MiniMed GroupMedical Devices | SEC FORM 4 Code A | —13,889 at $0.00 | filing |
| 2 Jun 2025filed 4 Jun 2025 | OM Outset MedicalMedical Devices | SEC FORM 4 Code A | —8,983 at $0.00 | filing |
| 3 Apr 2025filed 3 Apr 2025 | Nevro | SEC FORM 4 Code D | —228,552 | filing |
| 11 Mar 2025filed 11 Mar 2025 | Nevro | SEC FORM 4 Code F | $9,4851,641 at $5.78 | filing |
| 10 Mar 2025filed 11 Mar 2025 | OM Outset Medicaloption or derivative · Medical Devices | SEC FORM 4 Code M | —750 at $0.00 | filing |
| 10 Mar 2025filed 11 Mar 2025 | OM Outset MedicalMedical Devices | SEC FORM 4 Code M | —187,500 | filing |
| 7 Mar 2025filed 11 Mar 2025 | OM Outset Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | $150K750 at $200.00 | filing |
| 3 Mar 2025filed 4 Mar 2025 | Nevro | SEC FORM 4 Code F | $5,8171,017 at $5.72 | filing |
| 28 Feb 2025filed 4 Mar 2025 | Nevro | SEC FORM 4 Code A | —4,750 at $0.00 | filing |
| 28 Feb 2025filed 4 Mar 2025 | Nevro | SEC FORM 4 Code F | $6,1261,071 at $5.72 | filing |
| 3 Dec 2024filed 4 Dec 2024 | Nevro | SEC FORM 4 Code F | $3,953928 at $4.26 | filing |
| 3 Sep 2024filed 5 Sep 2024 | Nevro | SEC FORM 4 Code F | $5,6611,020 at $5.55 | filing |
| 3 Jun 2024filed 5 Jun 2024 | Nevro | SEC FORM 4 Code F | $11K1,134 at $9.33 | filing |
| 3 Jun 2024filed 3 Jun 2024 | OM Outset Medicaloption or derivative · Medical Devices | SEC FORM 4 Code M | —31,186 at $0.00 | filing |
| 3 Jun 2024filed 3 Jun 2024 | OM Outset Medicaloption or derivative · Medical Devices | SEC FORM 4 Code M | —38,117 at $0.00 | filing |
| 3 Jun 2024filed 3 Jun 2024 | OM Outset MedicalMedical Devices | SEC FORM 4 Code M | $35K31,186 at $1.11 | filing |
News
Terumo (OTCMKTS:TRUMY) & Intuitive Surgical (NASDAQ:ISRG) Financial AnalysisISRG · tickerreport.com · 22 Oct 2026Intuitive Surgical Surges 7.2% After Q3 Earnings Hit EDGARISRG · 247wallst.com · 21 Oct 2026Intuitive Surgical (NASDAQ:ISRG) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst SaysISRG · dailypolitical.com · 21 Oct 2026Outset Medical (NASDAQ:OM) vs. InspireMD (NYSE:NSPR) Financial ComparisonOM · tickerreport.com · 21 Oct 2026Head-To-Head Contrast: Femasys (NASDAQ:FEMY) versus Outset Medical (NASDAQ:OM)OM · dailypolitical.com · 18 Oct 2026
0 headlines in the last 90 days name D. Keith Grossman; 5 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.